文献速递重症综合管理与镇静镇痛

重症监护病房质量控制核查表的设计与应用

[Design and application of Checklist for quality control in intensive care unit].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2021-01-01
一句话结论在ICU实施质量控制核查表可降低三管感染发生率、标化死亡率和ICU住院时间,并提高质控执行率。

该研究设计了一套包含质控数据收集、病历质量核查、特殊诊疗和院感防控督导四部分的ICU质量控制核查表,由高级职称医师每月担任质控主任执行。回顾性分析2017年(未实施)与2018、2019年(实施)数据,2019年较2017年ICU住院时间缩短(9.14±7.02天 vs 10.20±7.21天),VAP、CRBSI、CAUTI发生率均显著下降,标化死亡率降低(70.61±7.49% vs 84.41±9.05%),抗菌治疗前病原学送检率和DVT预防率提高,差异均有统计学意义(P<0.05)。结论认为核查表应用可构建有效质控体系,促进医疗质量改进。

要点

  • 实施核查表后ICU住院时间显著缩短(2019年9.14±7.02天 vs 2017年10.20±7.21天,P<0.05)。
  • 三管感染率均显著下降:VAP 9.62±3.14 vs 17.48±4.89例/千通气日,CRBSI 3.87±1.87 vs 6.19±3.13例/千导管日,CAUTI 3.28±1.87 vs 5.61±3.18例/千导管日。
  • 标化死亡率显著降低(2019年70.61±7.49% vs 2017年84.41±9.05%,P<0.05)。
  • 抗菌治疗前病原学送检率(96.59±2.49% vs 87.86±5.28%)和DVT预防率(96.23±2.99% vs 85.58±7.68%)均显著提高(P<0.05)。

适用人群与场景

  • ICU收治的危重症患者,2017—2019年三年间入院人数分别为373、446、480例,三年患者平均年龄和APACHE II评分无统计学差异。
  • 实施场景为ICU病房,由每月一名高级职称医师担任质控主任,负责全科医疗质量管控。

诊断标准与关键阈值

  • 质量控制核查表设计依据包括《重症医学专业医疗质量控制指标(2015年版)》等指南和文献。
  • 核查表包含四部分:质控数据收集、病历质量核查、特殊诊疗、院感防控督导。
  • 质控主任每日晨交班时收集过去24小时数据,讨论并登记当日特殊诊疗行为,与护理组长协调,全天管控全科质量(监督不合理行为、检查运行和出院病历、巡查值班人员状态)。

处置流程与药物剂量

  • 第一步:每月指定一名高级职称医师担任质控主任,负责全科医疗质量管控。
  • 第二步:每日晨交班时收集过去24小时质控数据。
  • 第三步:讨论并登记当日将进行的特殊诊疗行为。
  • 第四步:与护理组长协调,全天监督每位医务人员不合理行为、检查运行和出院病历、巡查值班人员状态。
  • 药物剂量、给药途径、频次或疗程等具体信息原文未提及。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型为回顾性分析,单中心,比较2017年(未实施核查表)与2018、2019年(实施核查表)数据。
  • 2017—2019年入院人数分别为373、446、480例,2018年和2019年分别年增长19.57%和7.62%,2019年较2017年增长28.69%;三年患者平均年龄和APACHE II评分无统计学差异。
  • 与2017年相比,2018和2019年ICU住院时间显著缩短(天:8.99±6.12、9.14±7.02 vs 10.20±7.21),VAP、CRBSI、CAUTI发生率显著降低[VAP(例/千通气日):12.97±3.60、9.62±3.14 vs 17.48±4.89;CRBSI(例/千导管日):3.75±2.19、3.87±1.87 vs 6.19±3.13;CAUTI(例/千导管日):3.29±2.18、3.28±1.87 v
  • 三年所有病历均为甲级,但2018和2019年平均分高于2017年(96.82±2.84、96.73±2.94 vs 93.70±3.33,均P<0.01)。
  • 与2018年相比,2019年VAP发生率、抗菌治疗前病原学送检率、DVT预防率和标化死亡率进一步改善,每月院感防控不合规人次减少、特殊诊疗人次增加,差异均有统计学意义(均P<0.05)。

证据类型、等级与局限

  • 证据类型为单中心回顾性研究,非随机对照,存在设计局限(如历史对照、未随机化、单中心),原文未给出证据等级或推荐强度。

对床旁实践的改变

  • 在ICU实施结构化质量控制核查表(含质控数据收集、病历质量核查、特殊诊疗、院感防控督导)可降低三管感染发生率、标化死亡率和ICU住院时间,提高抗菌治疗前病原学送检率和DVT预防率。
  • 该干预适用于ICU病房质量管理,不适用于非ICU场景;原文未提及排除人群。
  • 常见陷阱:需每日由高级职称医师担任质控主任并全程执行,若执行不到位可能影响效果;原文为回顾性研究,因果推断需谨慎。

指南或共识出处

  • 原文引用《重症医学专业医疗质量控制指标(2015年版)》等指南和文献作为核查表设计依据。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVE: To design a Checklist for quality control in intensive care unit and observe the effect of clinical application.

METHODS: By consulting guidelines and literature, such as Critical care medicine professional medical quality control index (2015 edition), the quality control Checklist of intensive care unit was designed. It included four parts: quality control data collection, medical record quality verification, special diagnosis and treatment, and hospital infection prevention and control supervision. Every month, a doctor with a senior professional title served as the quality control director, and was responsible for the quality control of the department's medical care, including collecting data of the past 24 hours during the morning handover, discussing and registering special diagnosis and treatment behaviors that would be performed on the day, and coordinating with the nursing team leader, controlling the quality of the whole department throughout the day, such as supervising each medical staff if they had unreasonable behaviors, checking the running and discharge medical records, and inspecting the status of the staff on duty. The data in 2018, 2019 (Checklist implemented) and 2017 (Checklist not implemented) were retrospectively analyzed, including the status of admitted patients, department management information, length of intensive care unit (ICU) stay, and the incidence of three-tube infection [ventilator-associated pneumonia (VAP), catheter-related bloodstream infection (CRBSI), catheter-associated urinary tract infection (CAUTI)], and standardized mortality, etc.

RESULTS: From 2017 to 2019, the number of patients admitted was 373, 446, and 480, with annual growth of 19.57% and 7.62% in 2018 and 2019, respectively, and an increase of 28.69% in 2019 compared with 2017. There was no statistically significant difference in the average age and acute physiology and chronic health evaluation II (APACHE II) of patients in the three years. Compared with 2017, the length of ICU stay of patients in 2018 and 2019 were significantly shortened (days: 8.99±6.12, 9.14±7.02 vs. 10.20±7.21), and the incidence of VAP, CRBSI and CAUTI were significantly reduced [VAP (cases/1 000 ventilation days): 12.97±3.60, 9.62±3.14 vs. 17.48±4.89, CRBSI (cases/1 000 catheter days): 3.75±2.19, 3.87±1.87 vs. 6.19±3.13, CAUTI (cases/1 000 catheter days): 3.29±2.18, 3.28±1.87 vs. 5.61±3.18]. The standardized mortality were also significantly reduced [(77.27±7.24)%, (70.61±7.49)% vs. (84.41±9.05)%], the number of non-compliance with hospital infection prevention per month decreased significantly (person times: 54.00±6.30, 41.08±10.76 vs. 72.08±19.68), and the number of special diagnosis and treatment per month increased significantly (person times: 1 056.67±235.27, 1 361.75±278.48 vs. 722.25±145.96), the rate of etiology submission before antimicrobial treatment [(93.21±3.68)%, (96.59±2.49)% vs. (87.86±5.28)%] and deep vein thrombosis (DVT) prevention rate [(91.13±6.36)%, (96.23±2.99)% vs. (85.58±7.68)%] were significantly improved, and all the differences were statistically significant (all P < 0.05). All medical records in the three years were Grade A, but the average scores in 2018 and 2019 were higher than those in 2017 (96.82±2.84, 96.73±2.94 vs. 93.70±3.33, both P < 0.01). Compared with 2018, the incidence of VAP, the rate of etiology submission before antimicrobial treatment, the DVT prevention rate, and the standardized mortality rate in 2019 were further improved, and the number of non-compliance with hospital infection prevention per month decreased and the number of special diagnosis and treatment per month increased, and the differences were statistically significant (all P < 0.05).

CONCLUSIONS: The application of quality control Checklist in intensive care unit can build an effective quality control system, reduce the incidence of three-tube infection, standardized mortality and length of ICU stay, improve the quality control awareness and execution of medical staff, and promote the improvement of medical quality.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Zhao S, Zou Q, Zhang C, et al. [Design and application of Checklist for quality control in intensive care unit]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 34053492. doi:10.3760/cma.j.cn121430-20210207-00225

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。